These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 311085)

  • 21. From the NIH: New treatment for myoclonus patients.
    JAMA; 1980 May; 243(17):1705-6. PubMed ID: 6965990
    [No Abstract]   [Full Text] [Related]  

  • 22. L-5-hydroxytryptophan therapy in myoclonus.
    Van Woert MH; Rosenbaum D
    Adv Neurol; 1979; 26():107-15. PubMed ID: 316273
    [No Abstract]   [Full Text] [Related]  

  • 23. Spinal myoclonus: successful treatment with the combination of sodium valproate and L-5-hydroxytryptophan.
    Jiménez-Jiménez FJ; Roldan A; Zancada F; Molina-Arjona JA; Fernandez-Ballesteros A; Santos J
    Clin Neuropharmacol; 1991 Apr; 14(2):186-90. PubMed ID: 2015615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-5-hydroxytryptophan therapy in myoclonus: discussion.
    Adv Neurol; 1979; 26():117-22. PubMed ID: 316274
    [No Abstract]   [Full Text] [Related]  

  • 25. [Case of intention myoclonus (Lance-Adams syndrome) and a dramatic effect of L-5-hydroxytryptophan].
    Satoyoshi E; Kinoshita M; Takazawa Y; Yoda K
    Rinsho Shinkeigaku; 1976 Sep; 16(9):654-60. PubMed ID: 1087598
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical and metabolic observations on the treatment of myoclonus with L-5-HTP and carbidopa.
    Thal L; Sharpless N; Wolfson L; Engel J; Katzman R
    Trans Am Neurol Assoc; 1976; 101():48-52. PubMed ID: 1088459
    [No Abstract]   [Full Text] [Related]  

  • 27. Myoclonus, ataxia, and hypoventilation: response to L-5-hydroxytryptophan.
    Feit H; Kirkpatrick J; Van Woert MH; Pandian G
    Neurology; 1983 Jan; 33(1):109-12. PubMed ID: 6600288
    [No Abstract]   [Full Text] [Related]  

  • 28. Palatal myoclonus treated with 5-hydroxytryptophan and a decarboxylase-inhibitor.
    Magnussen I; Dupont E; Prange-Hansen A; de Fine Olivarius B
    Acta Neurol Scand; 1977 Mar; 55(3):251-53. PubMed ID: 300537
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of L-5HTP and drugs acting on serotonin metabolism in various myoclonic syndromes.
    Avanzini G; Bossi L; Caraceni T; Consolazione A; Franceschetti S; Negri S; Parati E
    Monogr Neural Sci; 1980; 5():142-52. PubMed ID: 6976509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myoclonus and L-5-hydroxytryptophan (L-5HTP).
    Van Woert MH
    Prog Clin Biol Res; 1983; 127():43-52. PubMed ID: 6351100
    [No Abstract]   [Full Text] [Related]  

  • 31. Posttraumatic intention myoclonus.
    Starosta-Rubinstein S; Bjork RJ; Snyder BD; Tulloch JW
    Surg Neurol; 1983 Aug; 20(2):131-2. PubMed ID: 6603671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Letter: Combination of a dopa decarboxylase inhibitor with 5-hydroxytryptophan therapy].
    Lhermitte F; Degos CF; Marteau R
    Nouv Presse Med; 1975 Jan; 4(1):31. PubMed ID: 1079935
    [No Abstract]   [Full Text] [Related]  

  • 33. Serotonin and myoclonus.
    Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
    Monogr Neural Sci; 1976; 3():71-80. PubMed ID: 790170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of myoclonic syndromes with paroxetine alone or combined with 5-HTP.
    Magnussen I; Mondrup K; Engbaek F; Lademann A; Olivarius BD
    Acta Neurol Scand; 1982 Aug; 66(2):276-82. PubMed ID: 6215817
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical, biochemical, and pharmacological observation in a patient with postasphyxic myoclonus: association to serotonin hyperactivity.
    Giménez-Roldán S; Mateo D; Muradas V; De Yebenes JG
    Clin Neuropharmacol; 1988 Apr; 11(2):151-60. PubMed ID: 2454156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of intravenous L-5-HTP in the myoclonic encephalopathy of infants.
    Gobbi G; Melideo G; Giovanardi Rossi P
    Neuropediatrics; 1986 May; 17(2):63-5. PubMed ID: 3014368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoxetine in the treatment of intention myoclonus.
    Van Woert MH; Magnussen I; Rosenbaum D; Chung E
    Clin Neuropharmacol; 1983 Mar; 6(1):49-54. PubMed ID: 6189599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intention and post-anoxic action myoclonias. Amelioration by piracetam].
    Cremieux C; Serratrice G
    Nouv Presse Med; 1979 Oct; 8(41):3357-8. PubMed ID: 534204
    [No Abstract]   [Full Text] [Related]  

  • 39. L-5 HTP available under treatment IND.
    FDA Drug Bull; 1983 Aug; 13(2):12-3. PubMed ID: 6604672
    [No Abstract]   [Full Text] [Related]  

  • 40. The pharmacology of myoclonus.
    Pranzatelli MR; Snodgrass SR
    Clin Neuropharmacol; 1985; 8(2):99-130. PubMed ID: 2988772
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.